#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=The amide bonds existing in a large number of structures and forming the backbone of the biologically essential proteins are the most basic building blocks of chemistry in nature .
2-1	16-19	The	object[3]	new[3]	coref	2-21[9_3]
2-2	20-25	amide	substance|object[3]	new|new[3]	coref	3-1[12_0]
2-3	26-31	bonds	object[3]	new[3]	_	_
2-4	32-40	existing	object[3]	new[3]	_	_
2-5	41-43	in	object[3]	new[3]	_	_
2-6	44-45	a	object[3]|abstract[4]	new[3]|new[4]	_	_
2-7	46-51	large	object[3]|abstract[4]	new[3]|new[4]	_	_
2-8	52-58	number	object[3]|abstract[4]	new[3]|new[4]	_	_
2-9	59-61	of	object[3]|abstract[4]	new[3]|new[4]	_	_
2-10	62-72	structures	object[3]|abstract[4]|abstract	new[3]|new[4]|new	coref	15-1[138_0]
2-11	73-76	and	object[3]	new[3]	_	_
2-12	77-84	forming	object[3]	new[3]	_	_
2-13	85-88	the	object[3]|abstract[6]	new[3]|new[6]	_	_
2-14	89-97	backbone	object[3]|abstract[6]	new[3]|new[6]	_	_
2-15	98-100	of	object[3]|abstract[6]	new[3]|new[6]	_	_
2-16	101-104	the	object[3]|abstract[6]|substance[7]	new[3]|new[6]|new[7]	coref	3-17[0_7]
2-17	105-117	biologically	object[3]|abstract[6]|substance[7]	new[3]|new[6]|new[7]	_	_
2-18	118-127	essential	object[3]|abstract[6]|substance[7]	new[3]|new[6]|new[7]	_	_
2-19	128-136	proteins	object[3]|abstract[6]|substance[7]	new[3]|new[6]|new[7]	_	_
2-20	137-140	are	_	_	_	_
2-21	141-144	the	object[9]	giv[9]	coref	3-11[16_9]
2-22	145-149	most	object[9]	giv[9]	_	_
2-23	150-155	basic	object[9]	giv[9]	_	_
2-24	156-164	building	place|object[9]	new|giv[9]	coref	14-10
2-25	165-171	blocks	object[9]	giv[9]	_	_
2-26	172-174	of	object[9]	giv[9]	_	_
2-27	175-184	chemistry	object[9]|abstract	giv[9]|new	_	_
2-28	185-187	in	object[9]	giv[9]	_	_
2-29	188-194	nature	object[9]|abstract	giv[9]|new	_	_
2-30	195-196	.	_	_	_	_

#Text=The amide is also essential due to its role in the peptide bonds in pharmaceuticals , proteins , and natural products .
3-1	197-200	The	substance[12]	giv[12]	ana	3-8[0_12]
3-2	201-206	amide	substance[12]	giv[12]	_	_
3-3	207-209	is	_	_	_	_
3-4	210-214	also	_	_	_	_
3-5	215-224	essential	_	_	_	_
3-6	225-228	due	_	_	_	_
3-7	229-231	to	_	_	_	_
3-8	232-235	its	substance|abstract[14]	giv|new[14]	coref|coref	4-1|6-15[49_14]
3-9	236-240	role	abstract[14]	new[14]	_	_
3-10	241-243	in	abstract[14]	new[14]	_	_
3-11	244-247	the	abstract[14]|object[16]	new[14]|giv[16]	coref	4-1[21_16]
3-12	248-255	peptide	abstract[14]|object|object[16]	new[14]|new|giv[16]	_	_
3-13	256-261	bonds	abstract[14]|object[16]	new[14]|giv[16]	_	_
3-14	262-264	in	abstract[14]|object[16]	new[14]|giv[16]	_	_
3-15	265-280	pharmaceuticals	abstract[14]|object[16]|substance	new[14]|giv[16]|new	_	_
3-16	281-282	,	abstract[14]|object[16]	new[14]|giv[16]	_	_
3-17	283-291	proteins	abstract[14]|object[16]|substance	new[14]|giv[16]|giv	_	_
3-18	292-293	,	abstract[14]|object[16]	new[14]|giv[16]	_	_
3-19	294-297	and	abstract[14]|object[16]	new[14]|giv[16]	_	_
3-20	298-305	natural	abstract[14]|object[16]|substance[19]	new[14]|giv[16]|new[19]	_	_
3-21	306-314	products	abstract[14]|object[16]|substance[19]	new[14]|giv[16]|new[19]	_	_
3-22	315-316	.	_	_	_	_

#Text=Amide bonds are characteristically synthesized by combining carboxylic acids and amines ; however , the association of these two functional groups does not occur at room temperature .
4-1	317-322	Amide	substance|object[21]	giv|giv[21]	_	_
4-2	323-328	bonds	object[21]	giv[21]	_	_
4-3	329-332	are	_	_	_	_
4-4	333-351	characteristically	_	_	_	_
4-5	352-363	synthesized	_	_	_	_
4-6	364-366	by	_	_	_	_
4-7	367-376	combining	_	_	_	_
4-8	377-387	carboxylic	person|substance[23]	new|new[23]	_	_
4-9	388-393	acids	substance[23]	new[23]	_	_
4-10	394-397	and	_	_	_	_
4-11	398-404	amines	substance	new	coref	5-43
4-12	405-406	;	_	_	_	_
4-13	407-414	however	_	_	_	_
4-14	415-416	,	_	_	_	_
4-15	417-420	the	abstract[25]	new[25]	_	_
4-16	421-432	association	abstract[25]	new[25]	_	_
4-17	433-435	of	abstract[25]	new[25]	_	_
4-18	436-441	these	abstract[25]|person[26]	new[25]|new[26]	_	_
4-19	442-445	two	abstract[25]|person[26]	new[25]|new[26]	_	_
4-20	446-456	functional	abstract[25]|person[26]	new[25]|new[26]	_	_
4-21	457-463	groups	abstract[25]|person[26]	new[25]|new[26]	_	_
4-22	464-468	does	_	_	_	_
4-23	469-472	not	_	_	_	_
4-24	473-478	occur	_	_	_	_
4-25	479-481	at	_	_	_	_
4-26	482-486	room	abstract[27]	new[27]	_	_
4-27	487-498	temperature	abstract[27]	new[27]	_	_
4-28	499-500	.	_	_	_	_

#Text=Over the past decades , many researchers have proposed alternative synthesis methods , such as the Staudinger reaction , direct amidation of aldehydes , transition-metal-catalyzed aminocarbonylation , and hydrating coupling of alkynes with azides , esters , alcohols , and alkynes with amines .
5-1	501-505	Over	_	_	_	_
5-2	506-509	the	time[28]	new[28]	_	_
5-3	510-514	past	time[28]	new[28]	_	_
5-4	515-522	decades	time[28]	new[28]	_	_
5-5	523-524	,	_	_	_	_
5-6	525-529	many	person[29]	new[29]	_	_
5-7	530-541	researchers	person[29]	new[29]	_	_
5-8	542-546	have	_	_	_	_
5-9	547-555	proposed	_	_	_	_
5-10	556-567	alternative	abstract[31]	new[31]	coref	7-6[60_31]
5-11	568-577	synthesis	abstract|abstract[31]	new|new[31]	coref	7-8[61_0]
5-12	578-585	methods	abstract[31]	new[31]	_	_
5-13	586-587	,	abstract[31]	new[31]	_	_
5-14	588-592	such	abstract[31]	new[31]	_	_
5-15	593-595	as	abstract[31]	new[31]	_	_
5-16	596-599	the	abstract[31]|event[33]	new[31]|new[33]	coref	8-25[74_33]
5-17	600-610	Staudinger	abstract[31]|person|event[33]	new[31]|new|new[33]	_	_
5-18	611-619	reaction	abstract[31]|event[33]	new[31]|new[33]	_	_
5-19	620-621	,	abstract[31]	new[31]	_	_
5-20	622-628	direct	abstract[31]|substance[34]	new[31]|new[34]	coref	8-28[0_34]
5-21	629-638	amidation	abstract[31]|substance[34]	new[31]|new[34]	_	_
5-22	639-641	of	abstract[31]|substance[34]	new[31]|new[34]	_	_
5-23	642-651	aldehydes	abstract[31]|substance[34]|substance	new[31]|new[34]|new	coref	8-31
5-24	652-653	,	abstract[31]	new[31]	_	_
5-25	654-680	transition-metal-catalyzed	abstract[31]|substance[36]	new[31]|new[36]	_	_
5-26	681-699	aminocarbonylation	abstract[31]|substance[36]	new[31]|new[36]	_	_
5-27	700-701	,	abstract[31]	new[31]	_	_
5-28	702-705	and	abstract[31]	new[31]	_	_
5-29	706-715	hydrating	abstract[31]	new[31]	_	_
5-30	716-724	coupling	abstract[31]|event[37]	new[31]|new[37]	_	_
5-31	725-727	of	abstract[31]|event[37]	new[31]|new[37]	_	_
5-32	728-735	alkynes	abstract[31]|event[37]|substance[38]	new[31]|new[37]|new[38]	coref	5-41[0_38]
5-33	736-740	with	abstract[31]|event[37]|substance[38]	new[31]|new[37]|new[38]	_	_
5-34	741-747	azides	abstract[31]|event[37]|substance[38]|plant	new[31]|new[37]|new[38]|new	_	_
5-35	748-749	,	abstract[31]|event[37]|substance[38]	new[31]|new[37]|new[38]	_	_
5-36	750-756	esters	abstract[31]|event[37]|substance[38]|substance	new[31]|new[37]|new[38]|new	_	_
5-37	757-758	,	abstract[31]|event[37]|substance[38]	new[31]|new[37]|new[38]	_	_
5-38	759-767	alcohols	abstract[31]|event[37]|substance[38]|substance	new[31]|new[37]|new[38]|new	_	_
5-39	768-769	,	abstract[31]|event[37]|substance[38]	new[31]|new[37]|new[38]	_	_
5-40	770-773	and	abstract[31]|event[37]|substance[38]	new[31]|new[37]|new[38]	_	_
5-41	774-781	alkynes	abstract[31]|event[37]|substance[38]|substance	new[31]|new[37]|new[38]|giv	coref	8-17[70_0]
5-42	782-786	with	_	_	_	_
5-43	787-793	amines	substance	giv	coref	8-33
5-44	794-795	.	_	_	_	_

#Text=Pyridyl benzamides are one of the most critical types of N-heterocyclic amides and play an essential role in the composition of many important medicines ( e.g. , antiulcer agents , kinetoplastid inhibitors , antifungal agents , and luciferase inhibitors ) .
6-1	796-803	Pyridyl	abstract|substance[45]	new|new[45]	coref|coref	7-11|7-11[63_45]
6-2	804-814	benzamides	substance[45]	new[45]	_	_
6-3	815-818	are	_	_	_	_
6-4	819-822	one	person[46]	new[46]	_	_
6-5	823-825	of	person[46]	new[46]	_	_
6-6	826-829	the	person[46]|place[47]	new[46]|new[47]	_	_
6-7	830-834	most	person[46]|place[47]	new[46]|new[47]	_	_
6-8	835-843	critical	person[46]|place[47]	new[46]|new[47]	_	_
6-9	844-849	types	person[46]|place[47]	new[46]|new[47]	_	_
6-10	850-852	of	person[46]|place[47]	new[46]|new[47]	_	_
6-11	853-867	N-heterocyclic	person[46]|place[47]|substance[48]	new[46]|new[47]|new[48]	coref	9-2[78_48]
6-12	868-874	amides	person[46]|place[47]|substance[48]	new[46]|new[47]|new[48]	_	_
6-13	875-878	and	_	_	_	_
6-14	879-883	play	_	_	_	_
6-15	884-886	an	abstract[49]	giv[49]	_	_
6-16	887-896	essential	abstract[49]	giv[49]	_	_
6-17	897-901	role	abstract[49]	giv[49]	_	_
6-18	902-904	in	abstract[49]	giv[49]	_	_
6-19	905-908	the	abstract[49]|abstract[50]	giv[49]|new[50]	_	_
6-20	909-920	composition	abstract[49]|abstract[50]	giv[49]|new[50]	_	_
6-21	921-923	of	abstract[49]|abstract[50]	giv[49]|new[50]	_	_
6-22	924-928	many	abstract[49]|abstract[50]|substance[51]	giv[49]|new[50]|new[51]	appos	6-26[53_51]
6-23	929-938	important	abstract[49]|abstract[50]|substance[51]	giv[49]|new[50]|new[51]	_	_
6-24	939-948	medicines	abstract[49]|abstract[50]|substance[51]	giv[49]|new[50]|new[51]	_	_
6-25	949-950	(	_	_	_	_
6-26	951-955	e.g.	person[52]|substance[53]	new[52]|giv[53]	_	_
6-27	956-957	,	person[52]|substance[53]	new[52]|giv[53]	_	_
6-28	958-967	antiulcer	person[52]|substance[53]	new[52]|giv[53]	_	_
6-29	968-974	agents	person[52]|substance[53]	new[52]|giv[53]	_	_
6-30	975-976	,	substance[53]	giv[53]	_	_
6-31	977-990	kinetoplastid	substance[53]|abstract|abstract[55]	giv[53]|new|new[55]	_	_
6-32	991-1001	inhibitors	substance[53]|abstract[55]	giv[53]|new[55]	_	_
6-33	1002-1003	,	substance[53]	giv[53]	_	_
6-34	1004-1014	antifungal	substance[53]|person[56]	giv[53]|new[56]	coref	26-28[245_56]
6-35	1015-1021	agents	substance[53]|person[56]	giv[53]|new[56]	_	_
6-36	1022-1023	,	substance[53]	giv[53]	_	_
6-37	1024-1027	and	substance[53]	giv[53]	_	_
6-38	1028-1038	luciferase	substance[53]|object|abstract[58]	giv[53]|new|new[58]	_	_
6-39	1039-1049	inhibitors	substance[53]|abstract[58]	giv[53]|new[58]	_	_
6-40	1050-1051	)	_	_	_	_
6-41	1052-1053	.	_	_	_	_

#Text=Lately , the number of methods for the synthesis of pyridyl benzamides has been rising significantly .
7-1	1054-1060	Lately	_	_	_	_
7-2	1061-1062	,	_	_	_	_
7-3	1063-1066	the	abstract[59]	new[59]	_	_
7-4	1067-1073	number	abstract[59]	new[59]	_	_
7-5	1074-1076	of	abstract[59]	new[59]	_	_
7-6	1077-1084	methods	abstract[59]|abstract[60]	new[59]|giv[60]	_	_
7-7	1085-1088	for	abstract[59]|abstract[60]	new[59]|giv[60]	_	_
7-8	1089-1092	the	abstract[59]|abstract[60]|abstract[61]	new[59]|giv[60]|giv[61]	_	_
7-9	1093-1102	synthesis	abstract[59]|abstract[60]|abstract[61]	new[59]|giv[60]|giv[61]	_	_
7-10	1103-1105	of	abstract[59]|abstract[60]|abstract[61]	new[59]|giv[60]|giv[61]	_	_
7-11	1106-1113	pyridyl	abstract[59]|abstract[60]|abstract[61]|abstract|substance[63]	new[59]|giv[60]|giv[61]|giv|giv[63]	coref	9-20[82_63]
7-12	1114-1124	benzamides	abstract[59]|abstract[60]|abstract[61]|substance[63]	new[59]|giv[60]|giv[61]|giv[63]	_	_
7-13	1125-1128	has	_	_	_	_
7-14	1129-1133	been	_	_	_	_
7-15	1134-1140	rising	_	_	_	_
7-16	1141-1154	significantly	_	_	_	_
7-17	1155-1156	.	_	_	_	_

#Text=Typical examples include the Cu-catalyzed oxidation of methyl ketones , Cu-catalyzed oxidative coupling of 2-aminopyridines and terminal alkynes with visible light mediation , and the direct oxidative amidation reaction of aldehydes with amines .
8-1	1157-1164	Typical	abstract[64]	new[64]	_	_
8-2	1165-1173	examples	abstract[64]	new[64]	_	_
8-3	1174-1181	include	_	_	_	_
8-4	1182-1185	the	event[65]	new[65]	coref	17-22[0_65]
8-5	1186-1198	Cu-catalyzed	event[65]	new[65]	_	_
8-6	1199-1208	oxidation	event[65]	new[65]	_	_
8-7	1209-1211	of	event[65]	new[65]	_	_
8-8	1212-1218	methyl	event[65]|abstract|substance[67]	new[65]|new|new[67]	_	_
8-9	1219-1226	ketones	event[65]|substance[67]	new[65]|new[67]	_	_
8-10	1227-1228	,	_	_	_	_
8-11	1229-1241	Cu-catalyzed	event[68]	new[68]	coref	17-28[0_68]
8-12	1242-1251	oxidative	event[68]	new[68]	_	_
8-13	1252-1260	coupling	event[68]	new[68]	_	_
8-14	1261-1263	of	event[68]	new[68]	_	_
8-15	1264-1280	2-aminopyridines	event[68]|substance	new[68]|new	_	_
8-16	1281-1284	and	event[68]	new[68]	_	_
8-17	1285-1293	terminal	event[68]|substance[70]	new[68]|giv[70]	_	_
8-18	1294-1301	alkynes	event[68]|substance[70]	new[68]|giv[70]	_	_
8-19	1302-1306	with	event[68]	new[68]	_	_
8-20	1307-1314	visible	event[68]|abstract[71]|abstract[72]	new[68]|new[71]|new[72]	_	_
8-21	1315-1320	light	event[68]|abstract[71]|abstract[72]	new[68]|new[71]|new[72]	_	_
8-22	1321-1330	mediation	event[68]|abstract[72]	new[68]|new[72]	_	_
8-23	1331-1332	,	_	_	_	_
8-24	1333-1336	and	_	_	_	_
8-25	1337-1340	the	event[74]	giv[74]	coref	12-9[107_74]
8-26	1341-1347	direct	event[74]	giv[74]	_	_
8-27	1348-1357	oxidative	event[74]	giv[74]	_	_
8-28	1358-1367	amidation	substance|event[74]	giv|giv[74]	coref	26-11
8-29	1368-1376	reaction	event[74]	giv[74]	_	_
8-30	1377-1379	of	event[74]	giv[74]	_	_
8-31	1380-1389	aldehydes	event[74]|substance	giv[74]|giv	_	_
8-32	1390-1394	with	event[74]	giv[74]	_	_
8-33	1395-1401	amines	event[74]|substance	giv[74]|giv	_	_
8-34	1402-1403	.	_	_	_	_

#Text=Since N-heterocyclic amides are increasingly being used in medicine , the discovery of a more effective approach to synthesize pyridyl benzamides is of great importance in the medical industry and has thus been attempted via numerous routes .
9-1	1404-1409	Since	_	_	_	_
9-2	1410-1424	N-heterocyclic	abstract|substance[78]	new|giv[78]	_	_
9-3	1425-1431	amides	substance[78]	giv[78]	_	_
9-4	1432-1435	are	_	_	_	_
9-5	1436-1448	increasingly	_	_	_	_
9-6	1449-1454	being	_	_	_	_
9-7	1455-1459	used	_	_	_	_
9-8	1460-1462	in	_	_	_	_
9-9	1463-1471	medicine	abstract	new	_	_
9-10	1472-1473	,	_	_	_	_
9-11	1474-1477	the	event[80]	new[80]	_	_
9-12	1478-1487	discovery	event[80]	new[80]	_	_
9-13	1488-1490	of	event[80]	new[80]	_	_
9-14	1491-1492	a	event[80]|abstract[81]	new[80]|new[81]	_	_
9-15	1493-1497	more	event[80]|abstract[81]	new[80]|new[81]	_	_
9-16	1498-1507	effective	event[80]|abstract[81]	new[80]|new[81]	_	_
9-17	1508-1516	approach	event[80]|abstract[81]	new[80]|new[81]	_	_
9-18	1517-1519	to	event[80]|abstract[81]	new[80]|new[81]	_	_
9-19	1520-1530	synthesize	event[80]|abstract[81]	new[80]|new[81]	_	_
9-20	1531-1538	pyridyl	event[80]|abstract[81]|substance[82]	new[80]|new[81]|giv[82]	_	_
9-21	1539-1549	benzamides	event[80]|abstract[81]|substance[82]	new[80]|new[81]|giv[82]	_	_
9-22	1550-1552	is	_	_	_	_
9-23	1553-1555	of	_	_	_	_
9-24	1556-1561	great	abstract[83]	new[83]	_	_
9-25	1562-1572	importance	abstract[83]	new[83]	_	_
9-26	1573-1575	in	abstract[83]	new[83]	_	_
9-27	1576-1579	the	abstract[83]|abstract[84]	new[83]|new[84]	_	_
9-28	1580-1587	medical	abstract[83]|abstract[84]	new[83]|new[84]	_	_
9-29	1588-1596	industry	abstract[83]|abstract[84]	new[83]|new[84]	_	_
9-30	1597-1600	and	_	_	_	_
9-31	1601-1604	has	_	_	_	_
9-32	1605-1609	thus	_	_	_	_
9-33	1610-1614	been	_	_	_	_
9-34	1615-1624	attempted	_	_	_	_
9-35	1625-1628	via	_	_	_	_
9-36	1629-1637	numerous	abstract[85]	new[85]	_	_
9-37	1638-1644	routes	abstract[85]	new[85]	_	_
9-38	1645-1646	.	_	_	_	_

#Text=Xiao-Lan Xu et al. synthesized N-pyridinyl benzamide from benzoylformic acid and aniline using a transition metal catalyst , AgOTf .
10-1	1647-1655	Xiao-Lan	person[86]	new[86]	_	_
10-2	1656-1658	Xu	person[86]	new[86]	_	_
10-3	1659-1661	et	_	_	_	_
10-4	1662-1665	al.	_	_	_	_
10-5	1666-1677	synthesized	_	_	_	_
10-6	1678-1689	N-pyridinyl	abstract|substance[88]	new|new[88]	coref|coref	11-9[97_88]|26-7
10-7	1690-1699	benzamide	substance[88]	new[88]	_	_
10-8	1700-1704	from	_	_	_	_
10-9	1705-1718	benzoylformic	substance[89]	new[89]	coref	11-14[101_89]
10-10	1719-1723	acid	substance[89]	new[89]	_	_
10-11	1724-1727	and	_	_	_	_
10-12	1728-1735	aniline	substance	new	_	_
10-13	1736-1741	using	_	_	_	_
10-14	1742-1743	a	object[93]	new[93]	coref	11-20[105_93]
10-15	1744-1754	transition	event|substance[92]|object[93]	new|new[92]|new[93]	_	_
10-16	1755-1760	metal	substance[92]|object[93]	new[92]|new[93]	_	_
10-17	1761-1769	catalyst	object[93]	new[93]	_	_
10-18	1770-1771	,	_	_	_	_
10-19	1772-1777	AgOTf	abstract	new	_	_
10-20	1778-1779	.	_	_	_	_

#Text=Additionally , Leiling Deng et al. also created N-pyridinyl benzamide from 2-aminopyridine and phenylacetic acid in the presence of a Cu salt catalyst .
11-1	1780-1792	Additionally	_	_	_	_
11-2	1793-1794	,	_	_	_	_
11-3	1795-1802	Leiling	person[95]	new[95]	_	_
11-4	1803-1807	Deng	person[95]	new[95]	_	_
11-5	1808-1810	et	abstract	new	_	_
11-6	1811-1814	al.	_	_	_	_
11-7	1815-1819	also	_	_	_	_
11-8	1820-1827	created	_	_	_	_
11-9	1828-1839	N-pyridinyl	substance[97]	giv[97]	coref	12-13[108_97]
11-10	1840-1849	benzamide	substance[97]	giv[97]	_	_
11-11	1850-1854	from	_	_	_	_
11-12	1855-1870	2-aminopyridine	substance|substance[99]	new|new[99]	coref|coref	12-16|12-16[110_99]
11-13	1871-1874	and	substance[99]	new[99]	_	_
11-14	1875-1887	phenylacetic	substance[99]|abstract|substance[101]	new[99]|new|giv[101]	_	_
11-15	1888-1892	acid	substance[99]|substance[101]	new[99]|giv[101]	_	_
11-16	1893-1895	in	_	_	_	_
11-17	1896-1899	the	abstract[102]	new[102]	_	_
11-18	1900-1908	presence	abstract[102]	new[102]	_	_
11-19	1909-1911	of	abstract[102]	new[102]	_	_
11-20	1912-1913	a	abstract[102]|object[105]	new[102]|giv[105]	coref	12-22[112_105]
11-21	1914-1916	Cu	abstract[102]|substance|substance[104]|object[105]	new[102]|new|new[104]|giv[105]	_	_
11-22	1917-1921	salt	abstract[102]|substance[104]|object[105]	new[102]|new[104]|giv[105]	_	_
11-23	1922-1930	catalyst	abstract[102]|object[105]	new[102]|giv[105]	_	_
11-24	1931-1932	.	_	_	_	_

#Text=Very recently , Zhengwang Chen et al. performed a reaction to synthesize N-pyridinyl benzamide from 2-aminopyridine and trans -β-nitrostyrene by utilizing Ce(NO3)3·6H2O catalyst in the absence of any oxidant or additive .
12-1	1933-1937	Very	_	_	_	_
12-2	1938-1946	recently	_	_	_	_
12-3	1947-1948	,	_	_	_	_
12-4	1949-1958	Zhengwang	person[106]	new[106]	_	_
12-5	1959-1963	Chen	person[106]	new[106]	_	_
12-6	1964-1966	et	_	_	_	_
12-7	1967-1970	al.	_	_	_	_
12-8	1971-1980	performed	_	_	_	_
12-9	1981-1982	a	event[107]	giv[107]	coref	22-25[211_107]
12-10	1983-1991	reaction	event[107]	giv[107]	_	_
12-11	1992-1994	to	event[107]	giv[107]	_	_
12-12	1995-2005	synthesize	event[107]	giv[107]	_	_
12-13	2006-2017	N-pyridinyl	event[107]|substance[108]	giv[107]|giv[108]	coref	26-7[239_108]
12-14	2018-2027	benzamide	event[107]|substance[108]	giv[107]|giv[108]	_	_
12-15	2028-2032	from	event[107]	giv[107]	_	_
12-16	2033-2048	2-aminopyridine	event[107]|substance|substance[110]	giv[107]|giv|giv[110]	coref	26-17
12-17	2049-2052	and	event[107]|substance[110]	giv[107]|giv[110]	_	_
12-18	2053-2058	trans	event[107]|substance[110]	giv[107]|giv[110]	_	_
12-19	2059-2074	-β-nitrostyrene	event[107]|substance[110]	giv[107]|giv[110]	_	_
12-20	2075-2077	by	_	_	_	_
12-21	2078-2087	utilizing	_	_	_	_
12-22	2088-2101	Ce(NO3)3·6H2O	substance|object[112]	new|giv[112]	coref	24-22[222_112]
12-23	2102-2110	catalyst	object[112]	giv[112]	_	_
12-24	2111-2113	in	_	_	_	_
12-25	2114-2117	the	_	_	_	_
12-26	2118-2125	absence	_	_	_	_
12-27	2126-2128	of	_	_	_	_
12-28	2129-2132	any	substance[113]	new[113]	_	_
12-29	2133-2140	oxidant	substance[113]	new[113]	_	_
12-30	2141-2143	or	_	_	_	_
12-31	2144-2152	additive	person	new	_	_
12-32	2153-2154	.	_	_	_	_

#Text=Metal – organic frameworks ( MOFs ) , a class of porous materials with excellent potential , have been increasingly used in gas storage and separation because of their high capacity and selectivity properties .
13-1	2155-2160	Metal	substance|object[116]	new|new[116]	coref	14-20
13-2	2161-2162	–	object[116]	new[116]	_	_
13-3	2163-2170	organic	object[116]	new[116]	_	_
13-4	2171-2181	frameworks	object[116]	new[116]	_	_
13-5	2182-2183	(	_	_	_	_
13-6	2184-2188	MOFs	abstract	new	appos	13-9[118_0]
13-7	2189-2190	)	_	_	_	_
13-8	2191-2192	,	_	_	_	_
13-9	2193-2194	a	abstract[118]	giv[118]	coref	16-6[0_118]
13-10	2195-2200	class	abstract[118]	giv[118]	_	_
13-11	2201-2203	of	abstract[118]	giv[118]	_	_
13-12	2204-2210	porous	abstract[118]|substance[119]	giv[118]|new[119]	ana	13-29[0_119]
13-13	2211-2220	materials	abstract[118]|substance[119]	giv[118]|new[119]	_	_
13-14	2221-2225	with	abstract[118]|substance[119]	giv[118]|new[119]	_	_
13-15	2226-2235	excellent	abstract[118]|substance[119]|abstract[120]	giv[118]|new[119]|new[120]	_	_
13-16	2236-2245	potential	abstract[118]|substance[119]|abstract[120]	giv[118]|new[119]|new[120]	_	_
13-17	2246-2247	,	_	_	_	_
13-18	2248-2252	have	_	_	_	_
13-19	2253-2257	been	_	_	_	_
13-20	2258-2270	increasingly	_	_	_	_
13-21	2271-2275	used	_	_	_	_
13-22	2276-2278	in	_	_	_	_
13-23	2279-2282	gas	substance|abstract[122]	new|new[122]	_	_
13-24	2283-2290	storage	abstract[122]	new[122]	_	_
13-25	2291-2294	and	_	_	_	_
13-26	2295-2305	separation	abstract	new	_	_
13-27	2306-2313	because	_	_	_	_
13-28	2314-2316	of	_	_	_	_
13-29	2317-2322	their	substance|abstract[125]	giv|new[125]	_	_
13-30	2323-2327	high	abstract[125]	new[125]	_	_
13-31	2328-2336	capacity	abstract[125]	new[125]	_	_
13-32	2337-2340	and	_	_	_	_
13-33	2341-2352	selectivity	abstract|abstract[127]	new|new[127]	coref	18-13
13-34	2353-2363	properties	abstract[127]	new[127]	_	_
13-35	2364-2365	.	_	_	_	_

#Text=MOF crystals are built through the formation of secondary building units ( SBUs ) consisting of organic linkers and metal ions/clusters .
14-1	2366-2369	MOF	abstract|object[129]	new|new[129]	coref	15-2
14-2	2370-2378	crystals	object[129]	new[129]	_	_
14-3	2379-2382	are	_	_	_	_
14-4	2383-2388	built	_	_	_	_
14-5	2389-2396	through	_	_	_	_
14-6	2397-2400	the	event[130]	new[130]	_	_
14-7	2401-2410	formation	event[130]	new[130]	_	_
14-8	2411-2413	of	event[130]	new[130]	_	_
14-9	2414-2423	secondary	event[130]|object[132]	new[130]|new[132]	_	_
14-10	2424-2432	building	event[130]|place|object[132]	new[130]|giv|new[132]	_	_
14-11	2433-2438	units	event[130]|object[132]	new[130]|new[132]	_	_
14-12	2439-2440	(	_	_	_	_
14-13	2441-2445	SBUs	abstract	new	_	_
14-14	2446-2447	)	_	_	_	_
14-15	2448-2458	consisting	_	_	_	_
14-16	2459-2461	of	_	_	_	_
14-17	2462-2469	organic	object[134]	new[134]	_	_
14-18	2470-2477	linkers	object[134]	new[134]	_	_
14-19	2478-2481	and	_	_	_	_
14-20	2482-2487	metal	substance|substance[136]	giv|new[136]	coref|coref	15-29|17-6[157_136]
14-21	2488-2501	ions/clusters	substance[136]	new[136]	_	_
14-22	2502-2503	.	_	_	_	_

#Text=Numerous MOF structures have been designed to obtain different features such as enlarged surface areas , enhanced catalytic activity and electrical conductivity , better interaction at the open metal sites , and improved adsorption .
15-1	2504-2512	Numerous	abstract[138]	giv[138]	_	_
15-2	2513-2516	MOF	abstract|abstract[138]	giv|giv[138]	coref	18-7
15-3	2517-2527	structures	abstract[138]	giv[138]	_	_
15-4	2528-2532	have	_	_	_	_
15-5	2533-2537	been	_	_	_	_
15-6	2538-2546	designed	_	_	_	_
15-7	2547-2549	to	_	_	_	_
15-8	2550-2556	obtain	_	_	_	_
15-9	2557-2566	different	abstract[139]	new[139]	_	_
15-10	2567-2575	features	abstract[139]	new[139]	_	_
15-11	2576-2580	such	abstract[139]	new[139]	_	_
15-12	2581-2583	as	abstract[139]	new[139]	_	_
15-13	2584-2592	enlarged	abstract[139]|place[141]	new[139]|new[141]	_	_
15-14	2593-2600	surface	abstract[139]|place|place[141]	new[139]|new|new[141]	coref	21-13
15-15	2601-2606	areas	abstract[139]|place[141]	new[139]|new[141]	_	_
15-16	2607-2608	,	abstract[139]	new[139]	_	_
15-17	2609-2617	enhanced	abstract[139]|abstract[142]	new[139]|new[142]	coref	18-10[172_142]
15-18	2618-2627	catalytic	abstract[139]|abstract[142]	new[139]|new[142]	_	_
15-19	2628-2636	activity	abstract[139]|abstract[142]	new[139]|new[142]	_	_
15-20	2637-2640	and	abstract[139]	new[139]	_	_
15-21	2641-2651	electrical	abstract[139]|abstract[143]	new[139]|new[143]	_	_
15-22	2652-2664	conductivity	abstract[139]|abstract[143]	new[139]|new[143]	_	_
15-23	2665-2666	,	abstract[139]	new[139]	_	_
15-24	2667-2673	better	abstract[139]|abstract[144]	new[139]|new[144]	_	_
15-25	2674-2685	interaction	abstract[139]|abstract[144]	new[139]|new[144]	_	_
15-26	2686-2688	at	abstract[139]|abstract[144]	new[139]|new[144]	_	_
15-27	2689-2692	the	abstract[139]|abstract[144]|place[146]	new[139]|new[144]|new[146]	coref	17-12[158_146]
15-28	2693-2697	open	abstract[139]|abstract[144]|place[146]	new[139]|new[144]|new[146]	_	_
15-29	2698-2703	metal	abstract[139]|abstract[144]|substance|place[146]	new[139]|new[144]|giv|new[146]	coref	17-3
15-30	2704-2709	sites	abstract[139]|abstract[144]|place[146]	new[139]|new[144]|new[146]	_	_
15-31	2710-2711	,	abstract[139]	new[139]	_	_
15-32	2712-2715	and	abstract[139]	new[139]	_	_
15-33	2716-2724	improved	abstract[139]|abstract[147]	new[139]|new[147]	_	_
15-34	2725-2735	adsorption	abstract[139]|abstract[147]	new[139]|new[147]	_	_
15-35	2736-2737	.	_	_	_	_

#Text=Notably , the application of MOFs as effective catalysts for organic reactions has received much attention .
16-1	2738-2745	Notably	_	_	_	_
16-2	2746-2747	,	_	_	_	_
16-3	2748-2751	the	abstract[148]	new[148]	_	_
16-4	2752-2763	application	abstract[148]	new[148]	_	_
16-5	2764-2766	of	abstract[148]	new[148]	_	_
16-6	2767-2771	MOFs	abstract[148]|abstract	new[148]|giv	coref	17-1[153_0]
16-7	2772-2774	as	abstract[148]	new[148]	_	_
16-8	2775-2784	effective	abstract[148]|substance[150]	new[148]|new[150]	_	_
16-9	2785-2794	catalysts	abstract[148]|substance[150]	new[148]|new[150]	_	_
16-10	2795-2798	for	abstract[148]|substance[150]	new[148]|new[150]	_	_
16-11	2799-2806	organic	abstract[148]|substance[150]|event[151]	new[148]|new[150]|new[151]	coref	17-17[159_151]
16-12	2807-2816	reactions	abstract[148]|substance[150]|event[151]	new[148]|new[150]|new[151]	_	_
16-13	2817-2820	has	_	_	_	_
16-14	2821-2829	received	_	_	_	_
16-15	2830-2834	much	abstract[152]	new[152]	_	_
16-16	2835-2844	attention	abstract[152]	new[152]	_	_
16-17	2845-2846	.	_	_	_	_

#Text=MOFs with metal nodes ( metal ions/clusters ) can act as the active catalytic sites for many organic reactions such as oxidation reactions , C – C coupling reactions , and hydrogenation reactions .
17-1	2847-2851	MOFs	abstract[153]	giv[153]	coref	20-6[0_153]
17-2	2852-2856	with	abstract[153]	giv[153]	_	_
17-3	2857-2862	metal	abstract[153]|substance|object[155]	giv[153]|giv|new[155]	coref	17-6
17-4	2863-2868	nodes	abstract[153]|object[155]	giv[153]|new[155]	_	_
17-5	2869-2870	(	_	_	_	_
17-6	2871-2876	metal	substance|substance[157]	giv|giv[157]	coref	19-6
17-7	2877-2890	ions/clusters	substance[157]	giv[157]	_	_
17-8	2891-2892	)	_	_	_	_
17-9	2893-2896	can	_	_	_	_
17-10	2897-2900	act	_	_	_	_
17-11	2901-2903	as	_	_	_	_
17-12	2904-2907	the	place[158]	giv[158]	_	_
17-13	2908-2914	active	place[158]	giv[158]	_	_
17-14	2915-2924	catalytic	place[158]	giv[158]	_	_
17-15	2925-2930	sites	place[158]	giv[158]	_	_
17-16	2931-2934	for	place[158]	giv[158]	_	_
17-17	2935-2939	many	place[158]|event[159]	giv[158]|giv[159]	coref	17-22[161_159]
17-18	2940-2947	organic	place[158]|event[159]	giv[158]|giv[159]	_	_
17-19	2948-2957	reactions	place[158]|event[159]	giv[158]|giv[159]	_	_
17-20	2958-2962	such	place[158]|event[159]	giv[158]|giv[159]	_	_
17-21	2963-2965	as	place[158]|event[159]	giv[158]|giv[159]	_	_
17-22	2966-2975	oxidation	place[158]|event[159]|event|event[161]|event[162]	giv[158]|giv[159]|giv|giv[161]|giv[162]	coref|coref	17-22[162_161]|17-25[166_162]
17-23	2976-2985	reactions	place[158]|event[159]|event[161]|event[162]	giv[158]|giv[159]|giv[161]|giv[162]	_	_
17-24	2986-2987	,	place[158]|event[159]|event[162]	giv[158]|giv[159]|giv[162]	_	_
17-25	2988-2989	C	place[158]|event[159]|event[162]|person[163]|event[166]	giv[158]|giv[159]|giv[162]|new[163]|giv[166]	coref|coref	17-27[0_163]|17-32[168_166]
17-26	2990-2991	–	place[158]|event[159]|event[162]|person[163]|event[166]	giv[158]|giv[159]|giv[162]|new[163]|giv[166]	_	_
17-27	2992-2993	C	place[158]|event[159]|event[162]|person[163]|person|event[166]	giv[158]|giv[159]|giv[162]|new[163]|giv|giv[166]	_	_
17-28	2994-3002	coupling	place[158]|event[159]|event[162]|event|event[166]	giv[158]|giv[159]|giv[162]|giv|giv[166]	coref	22-10
17-29	3003-3012	reactions	place[158]|event[159]|event[162]|event[166]	giv[158]|giv[159]|giv[162]|giv[166]	_	_
17-30	3013-3014	,	place[158]|event[159]|event[162]	giv[158]|giv[159]|giv[162]	_	_
17-31	3015-3018	and	place[158]|event[159]|event[162]	giv[158]|giv[159]|giv[162]	_	_
17-32	3019-3032	hydrogenation	place[158]|event[159]|event[162]|event|event[168]	giv[158]|giv[159]|giv[162]|new|giv[168]	coref	24-26[224_168]
17-33	3033-3042	reactions	place[158]|event[159]|event[162]|event[168]	giv[158]|giv[159]|giv[162]|giv[168]	_	_
17-34	3043-3044	.	_	_	_	_

#Text=However , the fabrication of a MOF structure with high activity and selectivity still requires further investigation .
18-1	3045-3052	However	_	_	_	_
18-2	3053-3054	,	_	_	_	_
18-3	3055-3058	the	abstract[169]	new[169]	_	_
18-4	3059-3070	fabrication	abstract[169]	new[169]	_	_
18-5	3071-3073	of	abstract[169]	new[169]	_	_
18-6	3074-3075	a	abstract[169]|abstract[171]	new[169]|new[171]	coref	25-25[235_171]
18-7	3076-3079	MOF	abstract[169]|abstract|abstract[171]	new[169]|giv|new[171]	coref	22-4[202_0]
18-8	3080-3089	structure	abstract[169]|abstract[171]	new[169]|new[171]	_	_
18-9	3090-3094	with	abstract[169]|abstract[171]	new[169]|new[171]	_	_
18-10	3095-3099	high	abstract[169]|abstract[171]|abstract[172]	new[169]|new[171]|giv[172]	coref	21-10[0_172]
18-11	3100-3108	activity	abstract[169]|abstract[171]|abstract[172]	new[169]|new[171]|giv[172]	_	_
18-12	3109-3112	and	abstract[169]|abstract[171]	new[169]|new[171]	_	_
18-13	3113-3124	selectivity	abstract[169]|abstract[171]|abstract	new[169]|new[171]|giv	_	_
18-14	3125-3130	still	_	_	_	_
18-15	3131-3139	requires	_	_	_	_
18-16	3140-3147	further	abstract[174]	new[174]	_	_
18-17	3148-3161	investigation	abstract[174]	new[174]	_	_
18-18	3162-3163	.	_	_	_	_

#Text=Recently , a new bimetallic metal – organic framework ( BMOF ) with a synergistic effect between different metal ions was developed .
19-1	3164-3172	Recently	_	_	_	_
19-2	3173-3174	,	_	_	_	_
19-3	3175-3176	a	object[176]	new[176]	_	_
19-4	3177-3180	new	object[176]	new[176]	_	_
19-5	3181-3191	bimetallic	object[176]	new[176]	_	_
19-6	3192-3197	metal	substance|object[176]	giv|new[176]	coref	19-19
19-7	3198-3199	–	object[176]	new[176]	_	_
19-8	3200-3207	organic	object[176]	new[176]	_	_
19-9	3208-3217	framework	object[176]	new[176]	_	_
19-10	3218-3219	(	_	_	_	_
19-11	3220-3224	BMOF	abstract	new	coref	20-22[188_0]
19-12	3225-3226	)	_	_	_	_
19-13	3227-3231	with	_	_	_	_
19-14	3232-3233	a	abstract[178]	new[178]	coref	24-10[218_178]
19-15	3234-3245	synergistic	abstract[178]	new[178]	_	_
19-16	3246-3252	effect	abstract[178]	new[178]	_	_
19-17	3253-3260	between	abstract[178]	new[178]	_	_
19-18	3261-3270	different	abstract[178]|substance[180]	new[178]|new[180]	coref	20-33[192_180]
19-19	3271-3276	metal	abstract[178]|substance|substance[180]	new[178]|giv|new[180]	coref	20-10
19-20	3277-3281	ions	abstract[178]|substance[180]	new[178]|new[180]	_	_
19-21	3282-3285	was	_	_	_	_
19-22	3286-3295	developed	_	_	_	_
19-23	3296-3297	.	_	_	_	_

#Text=Different from the synthesis of MOFs where only one metal ion is combined with organic ligands , the synthesis process of a BMOF produces the pure phase of the BMOF by combining two different metal ions with organic ligands .
20-1	3298-3307	Different	_	_	_	_
20-2	3308-3312	from	_	_	_	_
20-3	3313-3316	the	abstract[181]	new[181]	coref	20-19[0_181]
20-4	3317-3326	synthesis	abstract[181]	new[181]	_	_
20-5	3327-3329	of	abstract[181]	new[181]	_	_
20-6	3330-3334	MOFs	abstract[181]|abstract	new[181]|giv	coref	22-34[213_0]
20-7	3335-3340	where	abstract[181]	new[181]	_	_
20-8	3341-3345	only	abstract[181]|substance[184]	new[181]|new[184]	_	_
20-9	3346-3349	one	abstract[181]|substance[184]	new[181]|new[184]	_	_
20-10	3350-3355	metal	abstract[181]|substance|substance[184]	new[181]|giv|new[184]	coref	20-35
20-11	3356-3359	ion	abstract[181]|substance[184]	new[181]|new[184]	_	_
20-12	3360-3362	is	abstract[181]	new[181]	_	_
20-13	3363-3371	combined	abstract[181]	new[181]	_	_
20-14	3372-3376	with	abstract[181]	new[181]	_	_
20-15	3377-3384	organic	abstract[181]|substance[185]	new[181]|new[185]	coref	20-38[193_185]
20-16	3385-3392	ligands	abstract[181]|substance[185]	new[181]|new[185]	_	_
20-17	3393-3394	,	_	_	_	_
20-18	3395-3398	the	event[187]	new[187]	_	_
20-19	3399-3408	synthesis	abstract|event[187]	giv|new[187]	coref	24-26[223_0]
20-20	3409-3416	process	event[187]	new[187]	_	_
20-21	3417-3419	of	event[187]	new[187]	_	_
20-22	3420-3421	a	event[187]|abstract[188]	new[187]|giv[188]	coref	20-29[190_188]
20-23	3422-3426	BMOF	event[187]|abstract[188]	new[187]|giv[188]	_	_
20-24	3427-3435	produces	_	_	_	_
20-25	3436-3439	the	abstract[189]	new[189]	_	_
20-26	3440-3444	pure	abstract[189]	new[189]	_	_
20-27	3445-3450	phase	abstract[189]	new[189]	_	_
20-28	3451-3453	of	abstract[189]	new[189]	_	_
20-29	3454-3457	the	abstract[189]|abstract[190]	new[189]|giv[190]	coref	24-13[219_190]
20-30	3458-3462	BMOF	abstract[189]|abstract[190]	new[189]|giv[190]	_	_
20-31	3463-3465	by	_	_	_	_
20-32	3466-3475	combining	_	_	_	_
20-33	3476-3479	two	substance[192]	giv[192]	coref	22-13[207_192]
20-34	3480-3489	different	substance[192]	giv[192]	_	_
20-35	3490-3495	metal	substance|substance[192]	giv|giv[192]	_	_
20-36	3496-3500	ions	substance[192]	giv[192]	_	_
20-37	3501-3505	with	_	_	_	_
20-38	3506-3513	organic	substance[193]	giv[193]	_	_
20-39	3514-3521	ligands	substance[193]	giv[193]	_	_
20-40	3522-3523	.	_	_	_	_

#Text=The BMOFs are expected to have improved stability , activity , and surface area and could be applicable in catalysis .
21-1	3524-3527	The	abstract[194]	new[194]	coref	23-8[0_194]
21-2	3528-3533	BMOFs	abstract[194]	new[194]	_	_
21-3	3534-3537	are	_	_	_	_
21-4	3538-3546	expected	_	_	_	_
21-5	3547-3549	to	_	_	_	_
21-6	3550-3554	have	_	_	_	_
21-7	3555-3563	improved	abstract[195]	new[195]	_	_
21-8	3564-3573	stability	abstract[195]	new[195]	_	_
21-9	3574-3575	,	_	_	_	_
21-10	3576-3584	activity	abstract	giv	coref	22-21[208_0]
21-11	3585-3586	,	_	_	_	_
21-12	3587-3590	and	_	_	_	_
21-13	3591-3598	surface	place|abstract[198]	giv|new[198]	_	_
21-14	3599-3603	area	abstract[198]	new[198]	_	_
21-15	3604-3607	and	_	_	_	_
21-16	3608-3613	could	_	_	_	_
21-17	3614-3616	be	_	_	_	_
21-18	3617-3627	applicable	_	_	_	_
21-19	3628-3630	in	_	_	_	_
21-20	3631-3640	catalysis	abstract	new	coref	29-18[268_0]
21-21	3641-3642	.	_	_	_	_

#Text=For example , an Fe/Co mixed Hofmann MOF with coupling effects between Co2+ and Fe2+ ions was found to exhibit enhanced catalytic activity for an oxygen evolution reaction compared to that exhibited by the original single-metal MOFs .
22-1	3643-3646	For	_	_	_	_
22-2	3647-3654	example	_	_	_	_
22-3	3655-3656	,	_	_	_	_
22-4	3657-3659	an	abstract[202]	giv[202]	_	_
22-5	3660-3665	Fe/Co	abstract|abstract[202]	new|giv[202]	_	_
22-6	3666-3671	mixed	abstract[202]	giv[202]	_	_
22-7	3672-3679	Hofmann	person|abstract[202]	new|giv[202]	_	_
22-8	3680-3683	MOF	abstract[202]	giv[202]	_	_
22-9	3684-3688	with	abstract[202]	giv[202]	_	_
22-10	3689-3697	coupling	abstract[202]|event|abstract[204]	giv[202]|giv|new[204]	_	_
22-11	3698-3705	effects	abstract[202]|abstract[204]	giv[202]|new[204]	_	_
22-12	3706-3713	between	abstract[202]|abstract[204]	giv[202]|new[204]	_	_
22-13	3714-3718	Co2+	abstract[202]|abstract[204]|abstract|substance[207]	giv[202]|new[204]|new|giv[207]	_	_
22-14	3719-3722	and	abstract[202]|abstract[204]|substance[207]	giv[202]|new[204]|giv[207]	_	_
22-15	3723-3727	Fe2+	abstract[202]|abstract[204]|abstract|substance[207]	giv[202]|new[204]|new|giv[207]	_	_
22-16	3728-3732	ions	abstract[202]|abstract[204]|substance[207]	giv[202]|new[204]|giv[207]	_	_
22-17	3733-3736	was	_	_	_	_
22-18	3737-3742	found	_	_	_	_
22-19	3743-3745	to	_	_	_	_
22-20	3746-3753	exhibit	_	_	_	_
22-21	3754-3762	enhanced	abstract[208]	giv[208]	ana	22-31[212_208]
22-22	3763-3772	catalytic	abstract[208]	giv[208]	_	_
22-23	3773-3781	activity	abstract[208]	giv[208]	_	_
22-24	3782-3785	for	_	_	_	_
22-25	3786-3788	an	event[211]	giv[211]	coref	27-13[253_211]
22-26	3789-3795	oxygen	substance|abstract[210]|event[211]	new|new[210]|giv[211]	_	_
22-27	3796-3805	evolution	abstract[210]|event[211]	new[210]|giv[211]	_	_
22-28	3806-3814	reaction	event[211]	giv[211]	_	_
22-29	3815-3823	compared	_	_	_	_
22-30	3824-3826	to	_	_	_	_
22-31	3827-3831	that	abstract[212]	giv[212]	_	_
22-32	3832-3841	exhibited	abstract[212]	giv[212]	_	_
22-33	3842-3844	by	abstract[212]	giv[212]	_	_
22-34	3845-3848	the	abstract[212]|abstract[213]	giv[212]|giv[213]	_	_
22-35	3849-3857	original	abstract[212]|abstract[213]	giv[212]|giv[213]	_	_
22-36	3858-3870	single-metal	abstract[212]|abstract[213]	giv[212]|giv[213]	_	_
22-37	3871-3875	MOFs	abstract[212]|abstract[213]	giv[212]|giv[213]	_	_
22-38	3876-3877	.	_	_	_	_

#Text=Despite this , the catalysis applications of BMOFs have not been investigated so far .
23-1	3878-3885	Despite	_	_	_	_
23-2	3886-3890	this	_	_	_	_
23-3	3891-3892	,	_	_	_	_
23-4	3893-3896	the	abstract[214]	new[214]	_	_
23-5	3897-3906	catalysis	abstract[214]	new[214]	_	_
23-6	3907-3919	applications	abstract[214]	new[214]	_	_
23-7	3920-3922	of	abstract[214]	new[214]	_	_
23-8	3923-3928	BMOFs	abstract[214]|abstract	new[214]|giv	_	_
23-9	3929-3933	have	_	_	_	_
23-10	3934-3937	not	_	_	_	_
23-11	3938-3942	been	_	_	_	_
23-12	3943-3955	investigated	_	_	_	_
23-13	3956-3958	so	_	_	_	_
23-14	3959-3962	far	_	_	_	_
23-15	3963-3964	.	_	_	_	_

#Text=The main aim of this study was to appraise the effect of a new BMOF ( Fe2Ni-1,4-Benzenedicarboxylic , Fe2Ni-BDC ) as a heterogenous catalyst for organic synthesis reactions .
24-1	3965-3968	The	abstract[216]	new[216]	_	_
24-2	3969-3973	main	abstract[216]	new[216]	_	_
24-3	3974-3977	aim	abstract[216]	new[216]	_	_
24-4	3978-3980	of	abstract[216]	new[216]	_	_
24-5	3981-3985	this	abstract[216]|abstract[217]	new[216]|new[217]	_	_
24-6	3986-3991	study	abstract[216]|abstract[217]	new[216]|new[217]	_	_
24-7	3992-3995	was	_	_	_	_
24-8	3996-3998	to	_	_	_	_
24-9	3999-4007	appraise	_	_	_	_
24-10	4008-4011	the	abstract[218]	giv[218]	_	_
24-11	4012-4018	effect	abstract[218]	giv[218]	_	_
24-12	4019-4021	of	abstract[218]	giv[218]	_	_
24-13	4022-4023	a	abstract[218]|abstract[219]	giv[218]|giv[219]	appos	24-17[0_219]
24-14	4024-4027	new	abstract[218]|abstract[219]	giv[218]|giv[219]	_	_
24-15	4028-4032	BMOF	abstract[218]|abstract[219]	giv[218]|giv[219]	_	_
24-16	4033-4034	(	_	_	_	_
24-17	4035-4064	Fe2Ni-1,4-Benzenedicarboxylic	abstract	giv	appos	24-19
24-18	4065-4066	,	_	_	_	_
24-19	4067-4076	Fe2Ni-BDC	abstract	giv	coref	25-1
24-20	4077-4078	)	_	_	_	_
24-21	4079-4081	as	_	_	_	_
24-22	4082-4083	a	object[222]	giv[222]	coref	26-21[244_222]
24-23	4084-4096	heterogenous	object[222]	giv[222]	_	_
24-24	4097-4105	catalyst	object[222]	giv[222]	_	_
24-25	4106-4109	for	object[222]	giv[222]	_	_
24-26	4110-4117	organic	object[222]|abstract[223]|event[224]	giv[222]|giv[223]|giv[224]	_	_
24-27	4118-4127	synthesis	object[222]|abstract[223]|event[224]	giv[222]|giv[223]|giv[224]	_	_
24-28	4128-4137	reactions	object[222]|event[224]	giv[222]|giv[224]	_	_
24-29	4138-4139	.	_	_	_	_

#Text=Fe2Ni-BDC was generated by bridging iron ( III ) cations and nickel ( II ) cations with 1,4-Benzenedicarboxylic anions ( BDC− ) to create a porous three-dimensional structure .
25-1	4140-4149	Fe2Ni-BDC	abstract	giv	coref	26-19[243_0]
25-2	4150-4153	was	_	_	_	_
25-3	4154-4163	generated	_	_	_	_
25-4	4164-4166	by	_	_	_	_
25-5	4167-4175	bridging	_	_	_	_
25-6	4176-4180	iron	substance|abstract[228]	new|new[228]	_	_
25-7	4181-4182	(	abstract[228]	new[228]	_	_
25-8	4183-4186	III	person|abstract[228]	new|new[228]	_	_
25-9	4187-4188	)	abstract[228]	new[228]	_	_
25-10	4189-4196	cations	abstract[228]	new[228]	_	_
25-11	4197-4200	and	_	_	_	_
25-12	4201-4207	nickel	abstract|abstract[231]	new|new[231]	_	_
25-13	4208-4209	(	abstract[231]	new[231]	_	_
25-14	4210-4212	II	person|abstract[231]	new|new[231]	_	_
25-15	4213-4214	)	abstract[231]	new[231]	_	_
25-16	4215-4222	cations	abstract[231]	new[231]	_	_
25-17	4223-4227	with	_	_	_	_
25-18	4228-4251	1,4-Benzenedicarboxylic	abstract|substance[233]	new|new[233]	appos	25-21[0_233]
25-19	4252-4258	anions	substance[233]	new[233]	_	_
25-20	4259-4260	(	_	_	_	_
25-21	4261-4265	BDC−	substance	giv	_	_
25-22	4266-4267	)	_	_	_	_
25-23	4268-4270	to	_	_	_	_
25-24	4271-4277	create	_	_	_	_
25-25	4278-4279	a	abstract[235]	giv[235]	_	_
25-26	4280-4286	porous	abstract[235]	giv[235]	_	_
25-27	4287-4304	three-dimensional	abstract[235]	giv[235]	_	_
25-28	4305-4314	structure	abstract[235]	giv[235]	_	_
25-29	4315-4316	.	_	_	_	_

#Text=We also investigated the synthesis of N-pyridinyl benzamide via the amidation process of trans -β-nitrostyrene and 2-aminopyridine using Fe2Ni-BDC as an effective heterogeneous catalyst , without using added reducing agents or oxidizing agents .
26-1	4317-4319	We	person	acc	ana	29-5
26-2	4320-4324	also	_	_	_	_
26-3	4325-4337	investigated	_	_	_	_
26-4	4338-4341	the	event[237]	new[237]	_	_
26-5	4342-4351	synthesis	event[237]	new[237]	_	_
26-6	4352-4354	of	event[237]	new[237]	_	_
26-7	4355-4366	N-pyridinyl	event[237]|abstract|substance[239]	new[237]|giv|giv[239]	coref|coref	27-10|27-10[251_239]
26-8	4367-4376	benzamide	event[237]|substance[239]	new[237]|giv[239]	_	_
26-9	4377-4380	via	_	_	_	_
26-10	4381-4384	the	event[241]	new[241]	ana	27-20[0_241]
26-11	4385-4394	amidation	substance|event[241]	giv|new[241]	coref	27-14
26-12	4395-4402	process	event[241]	new[241]	_	_
26-13	4403-4405	of	event[241]	new[241]	_	_
26-14	4406-4411	trans	event[241]	new[241]	_	_
26-15	4412-4427	-β-nitrostyrene	event[241]	new[241]	_	_
26-16	4428-4431	and	event[241]	new[241]	_	_
26-17	4432-4447	2-aminopyridine	event[241]|substance	new[241]|giv	_	_
26-18	4448-4453	using	_	_	_	_
26-19	4454-4463	Fe2Ni-BDC	abstract[243]	giv[243]	coref	28-1[0_243]
26-20	4464-4466	as	abstract[243]	giv[243]	_	_
26-21	4467-4469	an	abstract[243]|object[244]	giv[243]|giv[244]	coref	27-1[248_244]
26-22	4470-4479	effective	abstract[243]|object[244]	giv[243]|giv[244]	_	_
26-23	4480-4493	heterogeneous	abstract[243]|object[244]	giv[243]|giv[244]	_	_
26-24	4494-4502	catalyst	abstract[243]|object[244]	giv[243]|giv[244]	_	_
26-25	4503-4504	,	_	_	_	_
26-26	4505-4512	without	_	_	_	_
26-27	4513-4518	using	_	_	_	_
26-28	4519-4524	added	person[245]|person[246]	giv[245]|giv[246]	coref|coref	26-28[246_245]|26-32[247_246]
26-29	4525-4533	reducing	person[245]|person[246]	giv[245]|giv[246]	_	_
26-30	4534-4540	agents	person[245]|person[246]	giv[245]|giv[246]	_	_
26-31	4541-4543	or	person[246]	giv[246]	_	_
26-32	4544-4553	oxidizing	person[246]|person[247]	giv[246]|giv[247]	_	_
26-33	4554-4560	agents	person[246]|person[247]	giv[246]|giv[247]	_	_
26-34	4561-4562	.	_	_	_	_

#Text=This catalyst might be reused for the creation of N-pyridinyl benzamide by the amidation reaction without significant depreciation in its efficiency .
27-1	4563-4567	This	object[248]	giv[248]	coref	28-13[260_248]
27-2	4568-4576	catalyst	object[248]	giv[248]	_	_
27-3	4577-4582	might	_	_	_	_
27-4	4583-4585	be	_	_	_	_
27-5	4586-4592	reused	_	_	_	_
27-6	4593-4596	for	_	_	_	_
27-7	4597-4600	the	event[249]	new[249]	_	_
27-8	4601-4609	creation	event[249]	new[249]	_	_
27-9	4610-4612	of	event[249]	new[249]	_	_
27-10	4613-4624	N-pyridinyl	event[249]|abstract|substance[251]	new[249]|giv|giv[251]	_	_
27-11	4625-4634	benzamide	event[249]|substance[251]	new[249]|giv[251]	_	_
27-12	4635-4637	by	_	_	_	_
27-13	4638-4641	the	event[253]	giv[253]	coref	28-18[261_253]
27-14	4642-4651	amidation	substance|event[253]	giv|giv[253]	_	_
27-15	4652-4660	reaction	event[253]	giv[253]	_	_
27-16	4661-4668	without	_	_	_	_
27-17	4669-4680	significant	abstract[254]	new[254]	_	_
27-18	4681-4693	depreciation	abstract[254]	new[254]	_	_
27-19	4694-4696	in	abstract[254]	new[254]	_	_
27-20	4697-4700	its	abstract[254]|event|abstract[256]	new[254]|giv|new[256]	_	_
27-21	4701-4711	efficiency	abstract[254]|abstract[256]	new[254]|new[256]	_	_
27-22	4712-4713	.	_	_	_	_

#Text=Fe2Ni-BDC is also satisfactory from the view of green chemistry , as the solid catalyst used for the reaction can be easily recovered and reused .
28-1	4714-4723	Fe2Ni-BDC	abstract	giv	_	_
28-2	4724-4726	is	_	_	_	_
28-3	4727-4731	also	_	_	_	_
28-4	4732-4744	satisfactory	_	_	_	_
28-5	4745-4749	from	_	_	_	_
28-6	4750-4753	the	abstract[258]	new[258]	_	_
28-7	4754-4758	view	abstract[258]	new[258]	_	_
28-8	4759-4761	of	abstract[258]	new[258]	_	_
28-9	4762-4767	green	abstract[258]|abstract[259]	new[258]|new[259]	_	_
28-10	4768-4777	chemistry	abstract[258]|abstract[259]	new[258]|new[259]	_	_
28-11	4778-4779	,	_	_	_	_
28-12	4780-4782	as	_	_	_	_
28-13	4783-4786	the	object[260]	giv[260]	_	_
28-14	4787-4792	solid	object[260]	giv[260]	_	_
28-15	4793-4801	catalyst	object[260]	giv[260]	_	_
28-16	4802-4806	used	object[260]	giv[260]	_	_
28-17	4807-4810	for	object[260]	giv[260]	_	_
28-18	4811-4814	the	object[260]|event[261]	giv[260]|giv[261]	_	_
28-19	4815-4823	reaction	object[260]|event[261]	giv[260]|giv[261]	_	_
28-20	4824-4827	can	_	_	_	_
28-21	4828-4830	be	_	_	_	_
28-22	4831-4837	easily	_	_	_	_
28-23	4838-4847	recovered	_	_	_	_
28-24	4848-4851	and	_	_	_	_
28-25	4852-4858	reused	_	_	_	_
28-26	4859-4860	.	_	_	_	_

#Text=To the best of our knowledge , C=C double bond cleavage has not previously been performed using heterogeneous catalysis .
29-1	4861-4863	To	_	_	_	_
29-2	4864-4867	the	abstract[262]	new[262]	_	_
29-3	4868-4872	best	abstract[262]	new[262]	_	_
29-4	4873-4875	of	abstract[262]	new[262]	_	_
29-5	4876-4879	our	abstract[262]|person|abstract[264]	new[262]|giv|new[264]	_	_
29-6	4880-4889	knowledge	abstract[262]|abstract[264]	new[262]|new[264]	_	_
29-7	4890-4891	,	_	_	_	_
29-8	4892-4895	C=C	abstract|abstract[266]|event[267]	new|new[266]|new[267]	_	_
29-9	4896-4902	double	abstract[266]|event[267]	new[266]|new[267]	_	_
29-10	4903-4907	bond	abstract[266]|event[267]	new[266]|new[267]	_	_
29-11	4908-4916	cleavage	event[267]	new[267]	_	_
29-12	4917-4920	has	_	_	_	_
29-13	4921-4924	not	_	_	_	_
29-14	4925-4935	previously	_	_	_	_
29-15	4936-4940	been	_	_	_	_
29-16	4941-4950	performed	_	_	_	_
29-17	4951-4956	using	_	_	_	_
29-18	4957-4970	heterogeneous	abstract[268]	giv[268]	_	_
29-19	4971-4980	catalysis	abstract[268]	giv[268]	_	_
29-20	4981-4982	.	_	_	_	_
